Back

Prognostic impact of RAASi and MRA Use in de novo HFrEF Patients with Renal Dysfunction and Hyperkalemia: Insights from the COEDO-AHF Registry"

1 September 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Novel therapies in heart failure: impact on outcomes Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Fumika Yoneyama

Saitama Medical Center, Kawagoe (Japan)

7 More presentations in this session

Presentation thumbnail
Clinical and echocardiographic long-term follow-up after transcoronary ablation of septal hypertrophy - a retrospective register analysis
Doctor F. Becker (Munich, DE)
Abstract Slides Video
Presentation thumbnail
High-dose guideline-directed medical therapy at discharge reduces mortality in hospitalized patients with heart failure with reduced ejection fraction: evidence from the HEROES study
Professor P. Krzesinski (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
The association between malnutrition and adverse outcome in patients with chronic heart failure who underwent cardiac resynchronization therapy
Doctor Y. Ono (Oita, JP)
Abstract Slides Video
Presentation thumbnail
Both BNP and left ventricle diastolic diameter can predict all-cause mortality among Colombian asymptomatic, Trypanosoma cruzi-seropositive carriers after 22 years: results of the CHICAMOCHA cohort
Professor J. Villar (Bogota, CO)
Abstract Slides Video
Presentation thumbnail
Prevalence and outcomes of iron deficiency based on transferrin saturation in patients with acute heart failure
Doctor K. Tsuda (Takatsuki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel therapies in heart failure: impact on outcomes

The Event

Event poster

ESC Congress 2025

1 September 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Dyskalaemia in heart failure.
23 May 2022
thumbnail
Congress Presentation
Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure on replacement therapy
19 May 2025
thumbnail
Congress Presentation
Optimisation of renin-angiotensin-aldosterone system inhibitors use in chronic kidney disease patients with heart failure: is hyperkalaemia a barrier?
17 May 2025
thumbnail
Congress Presentation
Discussant review - MRAs in heart failure
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources